These CKD-induced sleep disruptions are associated with significant upregulations of Per1 and Per2 mRNA expression in the hypothalamus, suggesting that a disrupted circadian timing system plays a role in the pathogenesis of sleep disturbance in patients with CKD, which is closely associated with the development of an attenuated dipping pattern of BP. This evidence concerns the gene PER2 and chronic kidney disease.